Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000842023-12-000040

CEO acquired 1,012 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

MELSEN GREGORY J · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2012-12-18 Exercise or conversion : show line 1 in the form +1,012 $49.43 $50,023 1,438 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-12-18 Exercise or conversion : show line 2 in the form Stock Option −1,012 $49.43 2013-07-26 1,012 0 D
Loading xslF345X03/primary_doc.xml…